ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 67.52% of GTBP shares are held by financial institutions. RETIREMENT GROUP, LLC is the top corporate investor, holding 1 shares valued at $4.00. A 0% stake in GT Biopharma, Inc. is owned by the company. JPMORGAN CHASE & CO owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the GTBP insiders holding of 12.15% of the stake in company, CATALDO TONY, CEO, holds the largest shares of 6.5M. WELDON STEVEN W, , is the second largest GTBP insider with ownership of 3.72M shares. BRISTOL INVESTMENT FUND LTD, 10 percent owner, stands third with possession of 1.53M shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GTBP shares is 22, representing 67.52% of the company's common stock.
RETIREMENT GROUP, LLC, in the last quarter, reduced its stake in GTBP by -97.73% restricting it's holding to 1 shares of worth nearly $4.00. JPMORGAN CHASE & CO also lessened -100% of the GTBP shares from its portfolio, reducing its holding to 0 shares of worth -. WELLS FARGO & COMPANY/MN also shunned GTBP shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, TWO SIGMA SECURITIES, LLC increased its stake in GTBP by 20.09% in the last quarter. The institutional holder raised its holding to 37.18 thousand shares having worth more than $9.48K. CITADEL ADVISORS LLC also added 100% more shares of GTBP to its portfolio, raising its holding to 57.81 thousand shares of worth $14.74K. UBS GROUP AG also increased its GTBP shares holding by 66.91% which brought its holding to 14.61 thousand shares worth $3.72K.
The insider with the most stakes in GTBP is Cataldo Tony , CEO at the company. Additionally, GTBP stock is highly held by Weldon Steven W and 10 percent owner BRISTOL INVESTMENT FUND LTD among others.
Company executives, directors, and other insiders own 12.15% percent of GT Biopharma, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which GTBP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include WELDON STEVEN W, CATALDO TONY, and URBANSKI RAYMOND W..
There have been 0 transaction(s) during the past 6-months in which GT Biopharma, Inc. insiders have bought stock, totalling 0 shares
Around 0 GT Biopharma, Inc. shares are held by insiders, which represents about 12.15% of GTBP stock.
GTBP CEO, Cataldo Tony holds the largest portfolio of the company's shares. GTBP shares owned by Cataldo total nearly 6.5 million.
RETIREMENT GROUP, LLC is the largest institutional owner in GTBP which holds 1 shares worth $4.00 or 0% of the total GTBP shares outstanding followed by JPMORGAN CHASE & CO with ownership of 0 shares representing 0% of the GTBP ownership. WELLS FARGO & COMPANY/MN is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GTBP is concerned, it is a stock which is not optionable.
Number of GTBP shares short is 17.73K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 2.23M shares of GTBP are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GTBP has 1.67M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GTBP is 0.71.